维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Nussbaum RL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Molecular confirmation of carriers for Lowe syndrome显示文摘	Lin T Lewis RA Nussbaum RL	1999	Ophthalmology1999，106，1：	1
2	The oculocerebrorenal syndrome gene product is a 105-k D protein localized to the Golgi complex显示文摘	Olivos-Glander IM Janne PA Nussbaum RL	1995	Am J Hum Genet1995，57，4：	1
3	Metal-catalyzed oxidation of alpha-synuclein:helping to define the relationship between oligomers,protofibrils,and filaments显示文摘	Cole NB Murphy DD Lebowitz J Di Noto L Levine RL Nussbaum RL		0，，：	1
4	The deficiency of PIP2 5-phospha-tase in Lowe syndrome affects actin polymerization 显示文摘	Suchy SF Nussbaum RL	2002	Am JHum Genet2002，71，6：	1
5	A threee-allele restriction-fragment-length polymorphism at the hprt locus in man 显示文摘	Crowder WE Nyhan WL	1983	Proc Natl Acad Sci USA1983，80，：	1
6	Physical mapping and genomic structure of the Lowe syndrome gene OCRL1 显示文摘	Nussbaum RL Orrison BM J]inne PA	1997	Hum Genet1997，99，：	1
7	Genetic testing before anticoagulation? A systematic review ofpharmacogenetic dosing of warfarin显示文摘	KANGELARIS KN BENT S NUSSBAUM RL	2009	J Gen Intern Med2009，24，5：	1
8	The protein product of the fragile X gene, FMR1 has characteristics of an RNAbinding protein显示文摘	Siomi H Siomi MC Nussbaum RL	1993	Cell1993，74，2：	1
9	Mapping of the Lowe oculocerebrorenal syndrome to Xq24-q26 by use of restriction fragment length polymorphisms显示文摘	Silver DN Lewis RA Nussbaum RL	1987	J Clin Invest1987，79，：	1
10	The protein product of the fragile X gene,FMR1 has characteristics of an RNA-binding protein显示文摘	Siomi h siomi MC Nussbaum RL	1993	Cell1993，74，2：	1
11	Genetic testing be- fore anticoagulation? A systematic review of pharmacogenetic dosing of warfarin显示文摘	Kangelaris KN Bent S Nussbaum RL	2009	J Gen Intern Med2009，24，5：	1
12	Molecular confirmation of carriers for Lowe syndrome显示文摘	Lin T Lewis RA Nussbaum RL	1999	Ophthalmology1999，106，：	1
13	Mapping X-linked ophthalmic disease:Provisional assignment of the locus for choroideremia to Xq13-q24显示文摘	Lewis RA Nussbaum RL Ferrell R	1985	Ophthalmology1985，92，：	1
14	Alzheimer's disease and Parkinson's disease显示文摘	Nussbaum RL Ellis CE	2003	N Engl J Med2003，348，14：	1
15	Genetic testing be- fore anticoagulation? A systematic review of pharmacogenetic dosing of warfarin显示文摘	Kangelaris KN Bent S Nussbaum RL	2009	J Gen Intern Med2009，24，：	1
16	The protein product of the fragile X gene, FMR1 has characteristics of an RNA binding protein显示文摘	Siomi MC Nussbaum RL	1993	Cell1993，74，2：	1
17	The protein product of the fragile X gene,FMR1 has characteristics of an RNA-binding protein显示文摘	Siomi H Siomi MC Nussbaum RL	1993	Cell1993，74，2：	1
18	Addressing the challenges of the clinical application of pharmacogenetic testing 显示文摘	Ikediobi ON Shin J Nussbaum RL	2009	Clin Pharmacol Ther2009，86，：	1
19	The protein product of the fragile X gene,FMRl has characterstics of an RNA-binding protein显示文摘	siomi MC Nussbaum RL	1993	Cell1993，74，2：	1
20	The protein product of the fragile X gene,FMR1,has characteristics of an RNA binding protein显示文摘	Siomi MC Nussbaum RL	1993	Cell1993，74，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示